A Trial of E7777 in Persistent and Recurrent Cutaneous T-Cell Lymphoma
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01871727 |
|
Recruitment Status :
Completed
First Posted : June 7, 2013
Last Update Posted : December 12, 2022
|
Sponsor:
Eisai Inc.
Collaborators:
Dr. Reddy's Laboratory
Citius Pharmaceuticals
Information provided by (Responsible Party):
Eisai Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | December 6, 2021 |
| Actual Study Completion Date : | December 14, 2021 |
| Certification/Extension First Submitted : | December 5, 2022 |